2-Br-2'-Oxo-PCM, 2-Br-DCK | |
---|---|
Molecular structure via molpic based on CDK |
Physical properties [] | |
---|---|
Molecular mass | 282.18 g/mol [1] |
Predicted LogP | 2.2 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C13H16BrNO [1] |
IUPAC name | 2-(2-bromophenyl)-2-(methylamino)cyclohexan-1-one [1] |
SMILES | CNC1(CCCCC1=O)C2=CC=CC=C2Br [1] |
InChI | InChI=1S/C13H16BrNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3 [1] |
InChIKey | XPMMBFIMXKSQIQ-UHFFFAOYSA-N [1] |
Bromoketamine
Bromoketamine (also known as 2-(2-bromophenyl)-2-(methylamino)cyclohexanone, 2-Bromo deschloroketamine, 2-Bromodeschloroketamine, Cyclohexanone, 2-(2-bromophenyl)-2-(methylamino)-, RefChem:197694, 2-(2-bromophenyl)-2-(methylamino)-cyclohexanone or 2(o-bromophenyl)-2-methylaminocyclohexanone) is a
Chemistry
Stereochemistry []
Bromoketamine is a racemic mixture of the enantiomers
Stereoisomers |
---|
Legal status
- Canada: Bromoketamine is a Schedule I substance.
- Germany: Bromoketamine is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: Bromoketamine is a Class B substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 71588007, Bromoketamine. Accessed September 6, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/71588007
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Bromoketamine. UNII: BG9ADQ6XT9. Global Substance Registration System. Accessed September 6, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/BG9ADQ6XT9